Skip to main content

Table 4 Baseline characteristics of the study population

From: Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome

Total N (%)

240 (100)

Age at diagnosis

71.6

Gender

 

 Female

101 (42.8)

 Male

139 (57.9)

Sub-location tumor

 

 Proximal

109 (45.4)

 Distal

87 (36.6)

 Rectosigmoid

44 (18.3)